Skip to main content
FinSpry Logo
FinSpry
ENGN logo
ENGN
(NASDAQ)
enGene Therapeutics Inc.
$1.77-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

enGene Therapeutics (ENGN) Stock Price & Financial Analysis

enGene Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.72 - $1.82
52-Week High$12.25
52-Week Low$1.40
Open$1.76
Volume1.67M
Average Volume (3M)1.66M
Market Cap119.23M
Shares Outstanding69.72M
Price to Book (P/B)0.47
EV/EBITDA-0.82
50-Day MA$3.88
200-Day MA$7.07
52-Week Change-43.38%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About enGene Therapeutics

What is the current stock price for ENGN?

As of the latest trading session, ENGN stock trades at $1.77. The 52-week range is $1.40–$12.25, with a day range of $1.72–$1.81.

What is the P/E ratio for ENGN?

The P/E ratio (Price-to-Earnings) for ENGN is shown in the Key Statistics section. This valuation metric helps compare enGene Therapeutics Inc. to industry peers.

Does ENGN pay dividends?

enGene Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ENGN?

Based on 11 analysts, the consensus for ENGN is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ENGN?

enGene Therapeutics's market capitalization is $123.4M, classifying it as a micro-cap company. enGene Therapeutics operates in the Healthcare sector within the Biotechnology industry.